(Q34601884)

English

A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Katsuyoshi Mizukami

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Takashi Asada

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Toru Kinoshita

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Katsuaki Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kazuki Sonohara

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ryuhei Nakai

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kiyoshi Yamaguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Haruo Hanyu

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kiyoshi Kanaya

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tetsuya Takao

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masakatsu Okada

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sumio Kudo

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hayato Kotoku

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masahiko Iwakiri

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hirofumi Kurita

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Toshihiro Miyamura

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yosuke Kawasaki

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Koji Omori

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kazumasa Shiozaki

19

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Toshinari Odawara

20

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tatsuya Suzuki

21

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shizuru Yamada

22

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Youichi Nakamura

23

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kenji Toba

24

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

191-199

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Old and ill and still feeling well? Determinants of subjective well-being in >or=60 year olds: the role of the sense of coherence.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine "ba wei di huang wan" in the treatment of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

The active principles of the branchlet and hook of Uncaria sinensis Oliv. examined with a 5-hydroxytryptamine receptor binding assay

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Event-related brain potential changes after Choto-san administration in stroke patients with mild cognitive impairments

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Risk of death in elderly users of conventional vs. atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

21 January 2018

Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570800970X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S146114570800970X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34601884&oldid=1603066793"